Pathologisches Institut
print


Navigationspfad


Inhaltsbereich

people_jung_lab

PEOPLE IN THE JUNG LAB  junglab

 

 ajungProf. Andreas Jung, PhD

Professor for Molecular Pathology academic director
background: biology, mathematics
AACR 1) Young Investigator Award h=48 (2018)

Principal Investigator: Tumormorphogenesis (Jung Lab) in the Max-Borst-Laboratory for Cancer
Research

DKTK 2)-Investigator (topic: Molecular Diagnostics, Early Detection and Biomarker Development)
vice-speaker of the AEK 3) of the DKG 4)

Head: Molekulare Pathologie diagnostic Molecular Pathology member of
Comprehensive Cancer Center LMU CCCM 5)
MTB (molecular tumor board) of the CCCM 6)
nNGM 7) at the partner site Munich - Taskforces 1a and 1b

interests

colorectal cancer
WNT/ β-catenin signaling: regulation of hallmarks of cancer by β-catenin target genes
plasticity of tumor cells (EMT-epithelio-mesenchymal transition)
molecular mechanisms cancer stemness EMT
chemoresitance metastasis

Publications
all years
2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010

contact

phone: ++49-89-2180-73630
E-Mail: andreas.jung@lmu.de

 

  jkumbrinkJörg Kumbrink PhD

 Senior Post-Doc biologist

 vice-head: Molecular Pathology diagnostic Molecular Pathology

member of the MTB (molecular tumor board) of the CCCM
member of the nNGM (nationales Netzwerk Genomische Medizin Lungenkrebs) partner site Munich - Taskforce 1a

Interests/ area of work

tumor biology
translational cancer research signal transduction chemoresistance
molecular pathology NGS-technology bioinformatics
molecular biology

contact:
phone: ++49-89-2180-73694
e-mail: Joerg.Kumbrink(at)med.uni-muenchen.de

 

jalbertJohanna Albert, B.Sc.

 Master student

Title of master thesis: Resistance against cetuximab mediated anti-EGFR treatment is mediated by the kinases EPHA2 and SRC

• Biologist
• B.Sc. at LMU Munich

contact:
e-mail: johanna.albert@med.uni-muenchen.de

 

 melmarsyManal Elmarsy

  PhD student

 co-supervision: Prof. David Horst, MD (director: Institute for Pathology Charité)

support by DAAD (German Academic Exchange Service)

Interests/ area of work

contact:

e-mail: Manal.Elmasry@med.uni-muenchen.de

 

 sheuckeSebastian Heucke, Dipl. Biol.

scientist

member of DKTK

IT and bioinformatics specialist in the Jung Lab

Interests/ area of work

NGS-technology bioinformatics
molecular biology

contact:

e-mail: Sebastian.Heucke@uni.med-muenchen.de

 

pliPan Li, M.Sc.

 MD-student

support by CSC (Chinese Scholarship Council - LMU site)

 M.Sc. work:

Wuhan University (2014-2017) Henan University (2014-2015)

contact:

e-mail: s-pali@helios.med.uni-muenchen.de

 

 cpeschelChristiane Peschel

 MD student

Molecular mechanisms of pharmacological resistance in colorectal cancer
against the FOLFIRI regime

Contact: Christiane.Peschel@med.uni-muenchen.de

 

 ssagebielSabine Sagebiel-Kohler

 technican

 topic/ area of interest

NGS-technology
molecular biologic work cell culture
laboratory organization

contact:

e-mail: Sabine.Sagebiel@med.uni-muenchen.de

 

ltorlotLucien Torlot

 MD-student

 support by: Studienstiftung des Deutschen Volkes

topic/ area of interest

mechanism of resistance in targeted anti-EGFR directed
treatment of colorectal cancer
proteomic analysis

cooperation with Küster-Lab

contact:

e-mail: Lucien.Torlot@med.uni-muenchen.de

 

apokÁgnes Pok-Ûdvari, M.Sc.

 scientist

 contact:

e-mail: Agnes.Udvari@med.uni-muenchen.de

 

 

 

 mwangMeng Wang, M.Sc.

 MD-student

support by Hebei Medical University, Shijiazhuang China

M.Sc. work: Detection and Clinical Significance of Circulating Tumor Cells and Tumor Stem Cells in Patients with Primary Breast Cancer
M.Sc.: Fourth Hospital of Hebei Medical University, Shijiazhuang China (2008-2011)
B.Sc.: Hebei Medical University, Shijiazhuang, China (2001-2006)

contact:

e-mail: Meng.Wang@med.uni-muenchen.de

 


1) American Association for Cancer Research
2) German Cancer Consortium
3) Working Group Experimental Cancer Research
4) German Cancer Society
5) , 6) Comprehensive Cancer Center München
7) national Network Genomic Medicine Lung cancer

 

 Stand: 07.11.2018